Table 6.
Secondary outcomes after HTX
| Parameter | All (n = 639) | No cRBBB ≤ 30 days after HTX (n = 500) | cRBBB ≤ 30 days after HTX (n = 139) | Difference | 95% CI | P‐value |
|---|---|---|---|---|---|---|
| 30‐day ≥ 1 graft rejection, n (%) | 118 (18.5%) | 99 (19.8%) | 19 (13.7%) | 6.1% | −0.6%–12.8% | 0.10 |
| 30‐day atrial fibrillation, n (%) | 88 (13.8%) | 58 (11.6%) | 30 (21.6%) | 10.0% | 2.6%–17.4% | < 0.01* |
| 30‐day bradycardia a , n (%) | 21 (3.3%) | 14 (2.8%) | 7 (5.0%) | 2.2% | −1.7%–6.1% | 0.19 |
| 30‐day PPM implantation, n (%) | 6 (0.9%) | 3 (0.6%) | 3 (2.2%) | 1.6% | −0.9%–4.1% | 0.09 |
| 1‐year PPM implantation, n (%) | 12 (1.9%) | 6 (1.2%) | 6 (4.3%) | 3.1% | 0.4%–6.6% | 0.02* |
CI, confidence interval; cRBBB, complete right bundle branch block; HTX, heart transplantation; n, number; PPM, permanent pacemaker.
a
Bradycardia defined as mean weekly heart rate < 60 beats per minute.
*
Statistically significant at P < 0.05.